A Dose-Escalation Study to Determine the Maximum Tolerated Dose of Arbaclofen Placarbil in Subjects With Alcohol Use Disorder
Condition(s):Alcohol Use DisorderLast Updated:January 23, 2017Completed
Hide Studies Not Open or Pending
Condition(s):Alcohol Use DisorderLast Updated:January 23, 2017Completed
Condition(s):Basal Cell CarcinomaLast Updated:March 12, 2024Terminated
Condition(s):Malignant Solid TumourLast Updated:February 10, 2022Completed
Condition(s):Advanced Solid TumorLast Updated:February 26, 2014Completed
Condition(s):Solid TumourLast Updated:July 30, 2019Completed
Condition(s):NeoplasmsLast Updated:October 1, 2014Terminated
Condition(s):Head and Neck NeoplasmLast Updated:February 18, 2021Terminated
Condition(s):Multiple MyelomaLast Updated:April 11, 2016Terminated
Condition(s):HIV InfectionsLast Updated:June 24, 2005Completed
Condition(s):Advanced Solid TumorsLast Updated:December 13, 2011Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.